Share on LinkedInShare on LinkedIn

ARTICLE · 09 JANUARY 2019

Health Care: New Rules For Hazardous-Waste Pharmaceuticals

Morrison Foerster
Morrison Foerster
Contributor
Morrison Foerster

Morrison Foerster

With approximately 1,000 lawyers in 19 offices, Morrison & Foerster is a preeminent global law firm...

View firm profile
Explore more from Morrison Foerster

The U.S. Environmental Protection Agency (EPA) will soon publish new rules that provide tailored standards for handling hazardous-waste pharmaceuticals in the health care sector.

United StatesEnvironment

The U.S. Environmental Protection Agency (EPA) will soon publish new rules that provide tailored standards for handling hazardous-waste pharmaceuticals in the health care sector. The rules streamline the requirements for the accumulating, labeling, shipping, and disposing of pharmaceutical waste classified as hazardous due to its ignitability, corrosivity, reactivity, and/or toxicity, or because it is specifically identified as hazardous under the Resource Conservation and Recovery Act (RCRA).

Prior Law: Previously, facilities generating hazardous-waste pharmaceuticals followed RCRA regulations, which vary depending on the amount and type of waste generated at the site. The new rules remove generators of hazardous-waste pharmaceuticals from the standard RCRA regulations and add tailored standards for these facilities.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

See more popular content from